Vontobel Holding’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.94M | Buy |
7,502
+163
| +2% | +$85.6K | 0.01% | 357 |
|
|
2025
Q1 | $4.65M | Buy |
7,339
+881
| +14% | +$559K | 0.02% | 328 |
|
|
2024
Q4 | $4.6M | Buy |
6,458
+2,322
| +56% | +$1.65M | 0.02% | 321 |
|
|
2024
Q3 | $4.35M | Sell |
4,136
-267
| -6% | -$281K | 0.01% | 340 |
|
|
2024
Q2 | $4.63M | Buy |
4,403
+683
| +18% | +$718K | 0.02% | 315 |
|
|
2024
Q1 | $3.58M | Sell |
3,720
-1,095
| -23% | -$1.05M | 0.03% | 362 |
|
|
2023
Q4 | $4.23M | Sell |
4,815
-3,855
| -44% | -$3.39M | 0.04% | 325 |
|
|
2023
Q3 | $7.14M | Buy |
8,670
+1,665
| +24% | +$1.37M | 0.07% | 246 |
|
|
2023
Q2 | $5.03M | Sell |
7,005
-101
| -1% | -$72.6K | 0.04% | 300 |
|
|
2023
Q1 | $5.84M | Sell |
7,106
-988
| -12% | -$812K | 0.05% | 267 |
|
|
2022
Q4 | $5.77M | Buy |
8,094
+2,167
| +37% | +$1.55M | 0.06% | 264 |
|
|
2022
Q3 | $4.08M | Sell |
5,927
-438
| -7% | -$302K | 0.05% | 291 |
|
|
2022
Q2 | $3.8M | Sell |
6,365
-1,186
| -16% | -$709K | 0.04% | 283 |
|
|
2022
Q1 | $5.23M | Sell |
7,551
-4,197
| -36% | -$2.91M | 0.05% | 279 |
|
|
2021
Q4 | $7.55M | Sell |
11,748
-1,616
| -12% | -$1.04M | 0.06% | 225 |
|
|
2021
Q3 | $8.09M | Buy |
13,364
+551
| +4% | +$333K | 0.07% | 200 |
|
|
2021
Q2 | $7M | Sell |
12,813
-1,230
| -9% | -$671K | 0.06% | 226 |
|
|
2021
Q1 | $6.65M | Buy |
14,043
+820
| +6% | +$388K | 0.05% | 218 |
|
|
2020
Q4 | $6.54M | Buy |
+13,223
| New | +$6.54M | 0.04% | 211 |
|